WCA
TELA icon

Waypoint Capital Advisors’s TELA Bio TELA Stock Holding History

Waypoint Capital Advisors’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40,000
Closed -$406K – 129
2023
Q2 		$406K Buy
+40,000
New +$409K 0.13% 98

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Waypoint Capital Advisors's TELA Position: Q3 2023 in Review

Waypoint Capital Advisors sold out of TELA Bio (TELA) in Q3 2023, closing a stake of 40,000 shares — an estimated $406K sold.

Waypoint Capital Advisors first reported a position in TELA in Q2 2023 and held it in 1 quarter. The position peaked at $406K in Q2 2023. 67 funds tracked by Wall St. Rank hold TELA as of Q3 2023.

  • Waypoint Capital Advisors reported no remaining TELA Bio position as of Q3 2023 after selling out during the quarter.
  • Waypoint Capital Advisors sold 40,000 TELA Bio shares in Q3 2023, an estimated $406K.
  • Waypoint Capital Advisors first reported a position in TELA Bio in Q2 2023 and held it in 1 quarter.
  • Waypoint Capital Advisors's TELA Bio position peaked at $406K in Q2 2023.
  • 67 funds tracked by Wall St. Rank held TELA Bio as of Q3 2023.

Based on Waypoint Capital Advisors's 13F filing for Q3 2023, filed 25 Oct 2023.